🚨 First ESC guideline dedicated to CVD + CKD at #ESCCongress. The key message: CKD should actively change cardiovascular management, not simply appear on the problem list. New STAMP on CKD framework: Screen Triage Address CKD risk Modify CVD management Plan care Major practical points: 🔹 Screen ALL patients with CVD using eGFR + albuminuria 🔹 SBP target 120-129 mmHg if tolerated when eGFR ≥30 🔹 ACEI/ARB + SGLT2i for most appropriate CKD patients 🔹 SGLT2i can be initiated at eGFR ≥20 🔹 Finerenone and GLP-1RA gain important roles in diabetic CKD 🔹 HF + CKD: SGLT2i irrespective of LVEF, with more aggressive decongestion when diuretic resistance develops 🔹 And an important clinical reminder: Kidney disease should not unnecessarily delay cardiovascular investigation or intervention. Treat the cardiorenal patient as one physiology, not two separate organs. @escardio @ERAkidney @ESC_Journals @willkidney @kevin_damman #CKD #Cardiorenal #HeartFailure